US Stock Insider Trading | Bio-Techne disclosed one insider trading transaction on February 5

K-LinePoet · 2026-02-06T00:10:32+00:00

Bio-Techne disclosed insider trading on February 5, 2026. Director Herr Amy E. sold 16 shares on February 3, for a total of $1,034.08. Additionally, several executives have recently engaged in stock transactions involving significant amounts. Bio-Techne is a company focused on life sciences, founded in 1981, and headquartered in Minnesota.

K-LinePoet

2026-02-06 00:10:32

Abstract generation in progress

On February 5, 2026, Bio-Techne (TECH) disclosed one insider transaction. Director Herr Amy E. sold 16 shares on February 3, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 5, 2026	Director	Herr Amy E.	February 3, 2026	Sell	16	64.63	1,034.08
February 3, 2026	Executive	McManus Matthew	February 1, 2026	Sell	1,665	64.09	$106,700
November 5, 2025	Executive	Geist William	November 3, 2025	Sell	4,520	62.57	$282,800
November 5, 2025	Executive	Hippel James	November 3, 2025	Sell	11,900	62.57	$742,400
November 5, 2025	Director	Kelderman Kim	November 3, 2025	Sell	2,303	62.57	$144,100
August 27, 2025	Director	BAUMGARTNER ROBERT V, Nusse Roeland	August 25, 2025	Buy	34,100	21.84	$744,300
August 27, 2025	Director	Nusse Roeland	August 25, 2025	Sell	17,000	56.36	$960,400
August 27, 2025	Director	BAUMGARTNER ROBERT V	August 25, 2025	Sell	17,000	56.21	$957,800
August 19, 2025	Director	Kelderman Kim	August 15, 2025	Sell	4,305	53.60	$230,700
August 19, 2025	Executive	Hippel James	August 15, 2025	Sell	1,926	53.60	$103,200

【Company Information】

Bio-Techne Corporation was founded on July 17, 1981, in Minnesota. Bio-Techne and its subsidiaries operate jointly to develop, manufacture, and sell life science reagents, instruments, and services for the global research, diagnostic, and bioprocessing markets. With its extensive product portfolio and application expertise, the company sells components of scientific investigations in bioprocessing and molecular diagnostics to reveal the nature, diagnosis, etiology, and progression of specific diseases.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.